On July 25, 2026, Zheng Jiangyun, Vice‑President of Yongzhou Intermediate People's Court, led a delegation to Hunan Hill Natural Pharmaceutical Co., Ltd. (hereinafter referred to as Hill Pharmaceutical) for a special follow‑up visit concerning the company’s business development after successful corporate reorganization. The delegation held a forum and conducted on‑site inspections of production workshops. The company’s management and representatives of the administrator gave a warm reception and attended the forum.

Research & Discussion: Jointly Advancing the "Post‑Reorganization Chapter

During the forum, President Zheng and his entourage learned in detail about Hill Pharmaceutical’s recovery of production and operation, reconstruction of the compliance management system, stability of its workforce, and market expansion following the completion of its reorganization plan. They focused on the difficulties currently confronting the enterprise and its demand for judicial services.

At the meeting, Hill Pharmaceutical reported the full restoration of business order post‑reorganization. Its workforce has remained stable with zero turnover of core key employees, and 60% of staff have worked for the company for over 15 years. Customer relationships have been steadily consolidated, order volumes have picked up gradually, and market confidence has improved markedly. Since the reorganization, the company has maintained smooth production and operation with a sound development momentum.

Extended Judicial Services: Addressing Challenges in Credit Repair

During the follow‑up visit, President Zheng’s team toured the company’s exhibition hall and workshops to learn about its products and manufacturing processes. Special attention was paid to the common credit‑repair difficulties faced by reorganized enterprises. Upon reviewing information such as closed‑end enforcement cases involving Hill Pharmaceutical, Yongzhou Intermediate People’s Court proactively collected relevant documents and assigned staff to follow up and coordinate solutions with the enterprise.

President Zheng stated, “Reorganization is not a one‑off liquidation, but targeted rescue tailored to each individual enterprise. The court shall continue follow‑up visits and extend judicial services to help enterprises not merely ‘survive’, but also ‘thrive’.” Meanwhile, President Zheng presented Hill Pharmaceutical with the Manual on Tips for Common Corporate Legal Risks. The manual is designed to help the enterprise identify legal risks accurately, master response strategies, strengthen its capacity for legal‑risk prevention and control, and safeguard its legitimate rights and interests in accordance with the law.

Looking Ahead: A New Start After Rebirth

This follow‑up visit constitutes a practical measure taken by Yongzhou Intermediate People's Court to implement the arrangements for the “Enterprise Service Year” and optimize the law‑based business environment. It also demonstrates the judiciary’s continuous care and commitment to safeguarding successfully reorganized enterprises. Taking this visit as an opportunity, Hill Pharmaceutical will stay focused on its core business, strengthen compliance‑driven operation, repay judicial support and public trust with solid achievements, and strive to write a new chapter of high‑quality development amid its rebirth from adversity.